| Application no. and date | 05820824.0 (espacenet) (Federated) (European Patent Register), 20051220 | | Patent/reg. no. and date | DK/EP 1830816, 20120801 | | Publication date | 20070912 | | Priority no. and date | US 638435 P, 20041222 | | EP pub. no. and date |
EP 1830816 20070912 | | Effective date | | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | AST101662 | | Inventor | Trofast, Eva, AstraZeneca R&D Lund
221 87 Lund, SE,
PERSSON, Eva, AstraZeneca R & D Lund
221 87 Lund, SE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/4439 (2006.01) , A61K 47/12 (2006.01) , A61K 47/26 (2006.01) , A61K 47/36 (2006.01) , A61K 9/10 (2006.01) , A61K 9/14 (2006.01) , A61K 9/16 (2006.01) | | Title | Fast doseringsform, der omfatter protonpumpeinhibitor, og suspension fremstillet deraf | | Int. application no. | SE2005001972 | | Int. publication no. | WO2006068596 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
